Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lawrence Mehren currently holds 762,381 shares of Accelerate Diagnostics, Inc (AXDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence Mehren has been a net buyer of AXDX stock. They have purchased $14.4M and sold $12.6M worth of shares.
Lawrence Mehren's most recent insider trade was on Aug 17, 2017, when they sold 223,215 shares at $22.40 per share.
Lawrence Mehren serves as Executive at Accelerate Diagnostics, Inc (AXDX). They have executed 11 insider transactions totaling $27.0M over their tenure at the company.
Lawrence Mehren holds the position of Executive at Accelerate Diagnostics, Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Lawrence Mehren has shown a buying trading pattern, with $14.4M in total purchases and $12.6M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Lawrence Mehren was on Jun 26, 2012, when they purchased $14.4M worth of AXK shares. This transaction involved 14,000,000 shares at $1.03 per share.
Lawrence Mehren currently owns 762,381 shares of Accelerate Diagnostics, Inc (AXDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lawrence Mehren's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lawrence Mehren has 11 Form 4 filings on record as an insider at Accelerate Diagnostics, Inc.
Set alerts for Lawrence Mehren and 40,000+ other insiders.